JP2012097036A5 - - Google Patents

Download PDF

Info

Publication number
JP2012097036A5
JP2012097036A5 JP2010246114A JP2010246114A JP2012097036A5 JP 2012097036 A5 JP2012097036 A5 JP 2012097036A5 JP 2010246114 A JP2010246114 A JP 2010246114A JP 2010246114 A JP2010246114 A JP 2010246114A JP 2012097036 A5 JP2012097036 A5 JP 2012097036A5
Authority
JP
Japan
Prior art keywords
acid
midges
spelling
guanine
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010246114A
Other languages
English (en)
Japanese (ja)
Other versions
JP5756615B2 (ja
JP2012097036A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010246114A priority Critical patent/JP5756615B2/ja
Priority claimed from JP2010246114A external-priority patent/JP5756615B2/ja
Publication of JP2012097036A publication Critical patent/JP2012097036A/ja
Publication of JP2012097036A5 publication Critical patent/JP2012097036A5/ja
Application granted granted Critical
Publication of JP5756615B2 publication Critical patent/JP5756615B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010246114A 2010-11-02 2010-11-02 オートインデューサー−２阻害剤、並びに歯周病又は齲蝕病の予防及び／又は治療剤 Active JP5756615B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010246114A JP5756615B2 (ja) 2010-11-02 2010-11-02 オートインデューサー−２阻害剤、並びに歯周病又は齲蝕病の予防及び／又は治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010246114A JP5756615B2 (ja) 2010-11-02 2010-11-02 オートインデューサー−２阻害剤、並びに歯周病又は齲蝕病の予防及び／又は治療剤

Publications (3)

Publication Number Publication Date
JP2012097036A JP2012097036A (ja) 2012-05-24
JP2012097036A5 true JP2012097036A5 (zh) 2013-10-31
JP5756615B2 JP5756615B2 (ja) 2015-07-29

Family

ID=46389379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010246114A Active JP5756615B2 (ja) 2010-11-02 2010-11-02 オートインデューサー−２阻害剤、並びに歯周病又は齲蝕病の予防及び／又は治療剤

Country Status (1)

Country Link
JP (1) JP5756615B2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7351296B2 (ja) * 2018-04-27 2023-09-27 ライオン株式会社 口腔内菌叢改善剤及び口腔用組成物
JP7359997B2 (ja) * 2019-09-26 2023-10-12 株式会社ファンケル ヒアルロン酸産生促進剤及びこれを含有するしわ改善剤又は皮膚外用剤
JP7421695B2 (ja) * 2019-09-26 2024-01-25 株式会社ファンケル メラニン産生抑制剤及びこれを含有する美白剤又は皮膚外用剤
EP3848016A1 (en) * 2020-01-08 2021-07-14 3M Innovative Properties Company Oral care composition containing fatty acid components for treating caries

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405585C2 (de) * 1993-03-03 1997-12-11 Beiersdorf Ag Verwendung von trans-Urocaninsäure zur Behandlung oder Prophylaxe der durch oxidative Beanspuchung hervorgerufenen Hautalterung
DE19817295A1 (de) * 1998-04-18 1999-10-21 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an unsymmetrisch substituiertenTriazinderivaten zum Erhalt des Urocaninsäurestatus der Haut
AU5716300A (en) * 1999-06-25 2001-01-31 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Method for scavenging radicals with urocanic acid, derivatives and analogues
FI20030379A0 (fi) * 2003-03-14 2003-03-14 Lasse Leino Uusi farmaseuttinen koostumus
JP2010159219A (ja) * 2009-01-07 2010-07-22 Kao Corp Ａｉ−２阻害剤

Similar Documents

Publication Publication Date Title
JP2007238598A5 (zh)
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
NO20100301L (no) Forbedrete brimonidinsammensetninger for behandling av erytem
EP2248519A3 (en) Non-mucoadhesive film dosage forms
UA110012C2 (uk) Лікарські форми для перорального застосування, що містять ацетат лікарбазепіну
EA201291410A1 (ru) Фармацевтические композиции, содержащие 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1h-бензимидазол-2-ил]-1h-хинолин-2-она лактат моногидрат
BR112013026802A2 (pt) estabilidade de peróxido melhorada em composições de tratamento oral
WO2013183062A3 (en) Palatable formulations of ibuprofen
EA202090029A1 (ru) Твердая композиция карипразина для орального введения
WO2011118976A3 (en) Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
CO6612204A2 (es) Nuevas composiciones de 1-(2(2.4 dimetil-fenilsulfanil)- fenil) piperazina
ECSP10010052A (es) Formulaciones galenicas de alisquireno y valsartan
WO2010090494A3 (ko) 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
JOP20220152A1 (ar) مشتقات 3-(5- ميثوكسي -1- أوكسو أيزو إندولين -2- يل) بيبريدين -2، 6- دايون واستخداماتها
JP2012508256A5 (zh)
PT2459153E (pt) Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
JP2012097036A5 (zh)
EP3999023A4 (en) METHOD FOR INCORPORATION OF OLEANOLIC ACID INTO ORAL CARE COMPOSITIONS AND ORAL CARE COMPOSITIONS BASED THEREOF
EP2384745A3 (en) Modified release pharmaceutical compositions of dexlansoprazole
JP2008088189A5 (zh)
WO2006079910A3 (en) 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity
JP2012097034A5 (zh)
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια